Top 55 Scott Gottlieb Quotes

The key to the generic-drug economic model is to keep entry prices low enough to attract multiple competitors.

Patients would be better off if states were able to tailor the benefits that Medicaid covers – targeting resources to sicker people and giving healthy adults cheaper, basic coverage.

Science offers the chance to cure debilitating and once-intractable disorders like hemophilia and sickle cell disease. But we need to make sure the ability to access these therapies, or the risk that someone can be locked out of them, doesn’t widen gaps between the rich and poor.

One option is to run Medicaid like a health program – rather than an exercise in political morals – and let states tailor benefits to the individual needs of patients, even if that means abandoning the unworkable myth of ‘comprehensive’ coverage.

Antibiotic resistance is as old as the dirt that coats our planet.

Covid-19 may be here for a long time.

Covid is likely to persist once its pandemic phase has passed and circulate each winter alongside the flu. Even after more of us contract coronavirus infection and develop immunity to it or even after an effective vaccine arrives, some people will still get very sick.

Our Founders thought politicians should be accountable when it comes to citizens’ right to life, liberty and the pursuit of heart surgery.

In countries such as France and Germany, layers of bureaucracy like health boards have been specifically engineered to delay the adoption of new medical products and services, thus lowering spending.

Why do physicians prescribe powerful antibiotics? Generally not because our patients ask for them. Most people who come in with a sore throat would be just as happy leaving my office with a prescription for Chloraseptic as clarithromycin.

Obamacare mandates a largely uniform structure and set of benefits and insurance design across the entire country. It leaves consumers with very little real choice of the health benefits they want.

More government control of doctors and their reimbursement schemes will only create more problems.

Among the most common reasons why people come to an emergency room are bouts of heart failure or pneumonia. Sometimes they have a touch of both.

Politicians wage broad wars on medicine to claim thin strips of ideological terrain. This would be good political theater if there weren’t so many human victims.

Before Obamacare, many working class Americans had an upper middle class healthcare benefit that they got at work.

It’s now evident that public health is part of national security.

Over the years, EpiPen’s manufacturer, Mylan, made meaningful modifications to its auto-injector pen. The company maintains some important intellectual property around these revisions. Mylan rightly argues that these features differentiate its device.

Covid-19 has altered world history.

Confronting a dangerous pandemic requires containing spread wherever it is reasonably possible. Sensible measures such as universal masking, testing and widespread and rapid contact tracing can help. The best way to protect the vulnerable is to try to protect everyone.

Even with all its political bells and whistles, the Obamacare plans increasingly resemble Medicaid in terms of networks and drug lists.

What makes the EpiPen unique is its delivery vehicle – an auto-injector that’s packaged in a convenient, pen-like device. The product’s key attribute is its ability to reliably deliver accurate doses of the essential medicine.

One of the biggest factors fueling the angst over drug prices in the U.S. is that some older medicines that should be sold cheaply as generics are still priced very high, often owing to a dwindling number of generic competitors and the rising cost of producing these drugs.

Once an effective drug is approved to treat a deadly condition, introducing a second drug to treat the same disease can be hard. It’s tough to recruit patients with a debilitating disease for a clinical trial when a proven medicine is already available.

Americans broadly consent to funding clinical research because they believe in the promise of medical research. But people support scientific work only if they trust that it serves societal interests, respects patient dignity and operates with guardrails.

In ‘Pox: An American History,’ Michael Willrich meticulously traces the story of how the smallpox vaccine was pressed into service during a major outbreak.

One of the striking features of the early episodes of AMC’s hit television show ‘Mad Men’ is the similarities in the lifestyle enjoyed by the lowest paid members of Don Draper’s advertising company and its wealthy partners.

We need to make sure that access to a curative drug doesn’t become a yardstick by which poverty is eventually measured. Doing so requires a shared commitment between innovators and the insurance plans that are harder pressed to offer these advances to the poor.

When gene therapy was believed to harbor latent risks, research was largely put on hold until the risks were better understood. Sometimes, the theoretical risks have led to a principle of absolutist precaution that impedes progress.

Obamacare’s costly regulations mean that the mix of people who sign up are tending to be older and sicker. Many young and otherwise healthy individuals continue to be priced out of the exchanges, even after the benefit of federal subsidies are baked into their costs.

Biologics must be grown in living systems – fermented, for example, in large vats of bacteria cells. This makes them hard to replicate. For decades, biologics weren’t subject to competition from copycat generic medicines, even once patents and exclusivities had lapsed on originals.

Gene editing will be used to alter DNA to erase the origins of a range of debilitating inherited disorders.

Gene therapies and other treatments that can cure – not just treat – disease are going to be expensive. All of the cost of innovating and reaping an economic return may need to be recouped in a single payment.

President Obama famously promised that the Affordable Care Act would not only slow the growth in health care costs, but would also reverse these trends, making the average health insurance plan cheaper. That isn’t happening.

The nature of food processing had changed substantially in America. Much of it owed to corresponding changes in food packaging and the logistics for faster shipping. The scope of outbreak from foodborne illness no longer has a clear geographic boundary.

Reformers in Washington need to do a better job of explaining how market-based alternatives to ObamaCare are a better outcome for the structure and delivery of health care.

The fact is, many poor patients visit ERs simply because they don’t have a family doctor.

One of the untold elements of the rapid decay underway in the Obamacare exchanges is the massive shift toward the Medicaid managed care companies, and away from the traditional commercial insurers like UnitedHealth Group and Aetna.

Many inherited disorders can perpetuate poverty by leading to disabilities that disrupt people’s ability to work. In turn, someone’s capacity to secure an effective new cure for these diseases can mean the difference between a life led productively, or one plagued by infirmity.

The authors of the Affordable Care Act wrongly assumed that new kinds of health plans, engineered in Washington, D.C., would emerge to displace the national for-profit insurers.

One thing about Covid-19 is clear: We don’t fully understand its severity and transmission. At various turns, we’ve both underestimated and overestimated the virus.

While faulty information from a digital health tool can influence people to make bad decisions, the risks are far lower than those posed by the usual products FDA subjects to pre-market review.

Printing novel DNA might open the way to achievements once only conceivable in science fiction: designer bacteria that can produce new chemicals, such as more efficient fuels, or synthetic versions of our cells that make us resistant to the effects of radiation.

When the price of a drug rises, it becomes profitable and the target of new competition.

There’s a big difference between apps that help you manage your medical information and draw clues from your own bodies, and those that seek to actively doctor you.

EpiPen is not unique. It falls into a category of old drugs, many of which should have long been subject to generic competition.

Before Obamacare, insurance networks typically covered an entire state. Under Obamacare, insurers are able to bid to offer coverage mostly on a county-by-county basis. It means that health plans only need to fashion doctor networks as wide as the county that they’re bidding to offer coverage in.

Regulators at the Food and Drug Administration have a tough job.

The period of time between the uncovering of some fundamental scientific finding that underpinned a medical advance, and the realization of the corresponding advance in the form of a new drug or medical technique that improves the health of patients, is being continually hastened.

A respiratory pathogen may pose an asymmetric risk to America, given our culture, economy and federalist system.

Health-assessment software such as CareEvolution’s ‘Safer Covid’ tool can combine multiple health factors to evaluate a person’s total risk of contracting Covid or suffering a bad outcome.